ARCHIVES

As Amgen, Johnson & Johnson Battle Over Anemia Market, Medicare Enters The Fray

This article is from The Cancer Letter archive.

Vol. 28 No. 46 | December 13, 2002

Download PDF Visit The Full Archive

Related Articles

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

June 5, 2009

Dexamethasone Improved Survival Of Leukemia

November 26, 2004

FDA Approvals: Lymphoseek Label Updated to Include Head and Neck SCC

June 27, 2014

AACI Adopts Plan To Step Up Cancer Issues Involvement

January 25, 1980

Physicians Not Giving Enough Narcotics For Effective Pain Control, M.D. Anderson Specialist Tells Seminar

April 14, 1989

Phase III PANORAMA-1 Trial Meets PFS Primary Endpoint

June 27, 2014